Background: Sickle cell disease is a common genetic disorder mainly characterized by vascular occlusion and haemolysis and it constitutes a major public health problem. The aim of this study is to assess the serum electrolyte levels in sickle cell patients attending the University of Nigeria Teaching Hospital, Enugu. Materials and methodology: A total of 66 subjects, ages 18 – 40 years, were recruited for this study with thirty sickle cell subjects (female = 16, Male = 14) as test subjects and thirty non-sickle cell subjects (female = 21, male = 9) as control subjects. A total of 5mls of venous blood was collected from each subject. The serum obtained from each sample was analyzed for serum electrolytes (sodium, potassium, chloride, and bicarbonate) by potentiometry using a sensacore autoanalyzer. The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 22. Results: Anthropometric results obtained from this study showed a significant decrease (P < 0.05) in mean ± SD of systolic blood pressure, diastolic blood pressure, and body mass index (BMI) in the test subjects compared to the control subjects respectively. The electrolyte analyses showed a significant increase (P < 0.05) in mean ± SD of potassium and chloride in the test subjects compared to the control subjects respectively. The control subjects have a non-significant increase (P > 0.05) mean ± SD of sodium compared to the sickle cell subjects while the sickle cell subject has a non-significant increase (P > 0.05) mean ± SD of bicarbonate compared to the control subjects. There was a positive correlation between sodium and bicarbonate, while in the other parameters; no significant correlation existed. Conclusion: This study concludes that sickle cell anaemia subjects are predisposed to electrolyte variations, hence, the need to check these electrolyte values in sickle cell subjects.
The blood level of C-reactive protein (CRP) has been postulated to increase in hypertensive patients but has not been implicated as a risk factor for high blood pressure. This prompted this study to investigate the level of CRP of hypertensive patients at the University of Nigeria Teaching Hospital, Ituku-Ozalla, and Enugu state. Eighty-nine subjects of which 50 were hypertensive patients (test subjects) and 39 apparently healthy individuals (control subjects) volunteered in the study. A structured questionnaire was used to capture the bio-data and other vital information from the participants of which virtually all the test subjects were on anti-hypertensive drugs. Anthropometric measurements were taken, blood samples were collected and CRP was analyzed using the Enzyme-Linked Immunosorbent Assay method. Data were analyzed using the student's test and Analysis of Variance (ANOVA). There was no significant statistical difference (P>0.05) in CRP levels (µg/ml) in all the comparisons; that is between all male and female study populations (401-478 and 3.61-4.24), between tests and controls (3.62-3.85 and 4.06-526), between male tests and male controls (3.76-3.55 and 4.24-5.80), between female tests and female control (3.62 ±3.85 and 3.76-3.55) between male tests and female tests (3.50-414 and 381-4.531, and between male controls and female controls (4.24 ±5.80 and 3.81-4.55). It was also observed that there was no relationship between the duration of hypertension with the CRP levels in the test subjects. These results suggest that the C-reactive protein levels may be increased in hypertensive patients but may be decreased by antihypertensive therapies. More studies are needed and these findings warrant further evaluation in randomized trials. A longitudinal study to fully assess the effect of antihypertensive drugs on the level of C-reactive protein in hypertensive patients may also be of great essence.
Background: In pregnancy which is a physiological state that is accompanied by high energy demand, there is an increased intake and utilization of oxygen, hence augmented levels of oxidative changes that are associated with a lot of risks, one of which is cardiovascular diseases. This research aims to investigate the oxidative changes that occur among pregnant women by determining the levels of High Sensitivity c-Reactive Protein (hs-CRP) and Oxidized Low-Density Lipoprotein (OxLDL) in first, second and third trimesters. Materials and Methodology: A total of 60 pregnant women were recruited for the study. Twenty (20) pregnant women each from the three trimesters while Twenty (20) non-pregnant pubertal women without any chronic disease were used as control. 5ml of venous blood was collected from all subjects and analyzed for OxLDL and hs-CRP using an Enzyme-Linked Immunosorbent Assay (ELISA) technique. The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 18. Results: Oxidized Low-Density Lipoprotein (OxLDL) showed mean variations across the groups but was not significant (P>0.05) but Pregnant women in their second trimester showed significant mean variation (P<0.05) (3716.11±599.86) in when compared to non-pregnant women (control) (4305.33±68.90) respectively. Pregnant women in the second trimester showed significantly decreased mean variation (P<0.05) in High sensitivity C-reactive protein (85.09 ±12.38) when compared to non-pregnant women (control) (219.45 ±64.61) respectively. Conclusions: This study shows that there are increases in levels of OxLDL and a decrease in plasma concentration of hs-CRP which are more significant in the second trimester.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.